| Filed On | Filing |
|---|---|
| 04 Nov 2026 |
Form 4: Epstein David R, Director
Sold 370 shares ($27.5K) |
| 04 Nov 2026 |
Form 4: Fukushima Ryan, CEO, Data
Received 100,000 shares as a grant or award · Sold 80 shares ($5.94K) |
| 29 Oct 2026 |
Form 4: Lefkofsky Eric P, Director
Sold 250,000 shares ($17.6M) |
| 29 Sep 2026 |
Form 4: Schoenherr Thomas Edward, CEO, Diagnostics
Sold 10,281 shares ($874K) |
| 24 Sep 2026 |
Form 4: Lefkofsky Eric P, Director
Sold 250,000 shares ($19.4M) |
| 18 Sep 2026 |
Form 4: Lefkofsky Eric P, Director
Sold 200,000 shares ($16.1M) |
| 18 Sep 2026 |
Form 4: Bartolucci Ryan M, Chief Accounting Officer
Sold 7,062 shares ($530K) |
| 18 Sep 2026 |
Form 4: Polovin Andrew, EVP, Chief Legal Officer
Sold 2,951 shares ($221K) |
| 18 Sep 2026 |
Form 4: Fukushima Ryan, CEO, Data
Sold 700 shares ($49K) |
| 03 Sep 2026 |
Form 4: Fukushima Ryan, CEO, Data
Sold 30,846 shares ($1.93M) |
| 03 Sep 2026 |
Form 4: Doudna Jennifer A, Director
Sold 676 shares ($44.3K) |
| 03 Sep 2026 |
Form 4: Epstein David R, Director
Sold 250 shares ($16.4K) |
| 01 Sep 2026 |
Form 4: West Nadja, Director
Sold 3,000 shares ($207K) |
| 27 Aug 2026 |
Form 4: Lefkofsky Eric P, Director
Sold 11,848 shares ($828K) |
| 27 Aug 2026 |
Form 4: Lefkofsky Eric P, Director
Sold 238,152 shares ($16.3M) |
| 25 Aug 2026 |
Form 4: Schoenherr Thomas Edward, CEO, Diagnostics
Acquired 2,694 shares (Open Market Sale) ($189K) |
| 25 Aug 2026 |
Form 4: Fukushima Ryan, CEO, Data
Sold 14,286 shares ($1M) |
| 20 Aug 2026 |
Form 4: Fukushima Ryan, CEO, Data
Sold 41,095 shares ($2.04M) |
| 20 Aug 2026 |
Form 4: Lefkofsky Eric P, Director
Sold 132,591 shares ($6.58M) |
| 20 Aug 2026 |
Form 4: Schoenherr Thomas Edward, CEO, Diagnostics
Sold 9,232 shares ($458K) · Sold 8,082 shares ($472K) |
Loading...